876 reports of this reaction
3.5% of all CEFEPIME reports
#4 most reported adverse reaction
PYREXIA is the #4 most commonly reported adverse reaction for CEFEPIME, manufactured by Apotex Corp.. There are 876 FDA adverse event reports linking CEFEPIME to PYREXIA. This represents approximately 3.5% of all 25,295 adverse event reports for this drug.
Patients taking CEFEPIME who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PYREXIA is moderately reported among CEFEPIME users, representing a notable but not dominant share of adverse events.
In addition to pyrexia, the following adverse reactions have been reported for CEFEPIME:
The following drugs have also been linked to pyrexia in FDA adverse event reports:
PYREXIA has been reported as an adverse event in 876 FDA reports for CEFEPIME. This does not prove causation, but indicates an association observed in post-market surveillance data.
PYREXIA accounts for approximately 3.5% of all adverse event reports for CEFEPIME, making it a notable side effect.
If you experience pyrexia while taking CEFEPIME, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.